News
Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug ...
Merck (MRK) stock in focus as the FDA approves its anticancer agent Welireg for two rare neuroendocrine tumors, expanding its ...
MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...
Biohaven shares slipped after the Food and Drug Administration extended the Prescription Drug User Fee Act date for the biopharmaceutical company's troriluzole application by three months. The stock ...
Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...
The company reported a net loss attributable to common stockholders of $5.0 million, or $0.18 per share, for the three months ended March 31, 2025, compared to a net loss attributable to common ...
We recently published a list of 12 Best Quantum Computing Stocks to Invest in Now. In this article, we are going to take a ...
Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.
13hon MSN
We recently published a list of 12 Best Quantum Computing Stocks to Invest in Now. In this article, we are going to take a ...
A new all-in-one pulsed field ablation catheter system demonstrated durable pulmonary vein isolation and a promising safety ...
12h
CNET on MSNCheck Your Eye Drops: 75,000 Cases Were Just RecalledAccording to the FDA, over 75,000 cases of five different eye drops and artificial tears were recalled. Here's what you need ...
While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results